Clinical evidence of interaction between itraconazole and nonnucleoside reverse transcriptase inhibitors in HIV-infected patients with disseminated histoplasmosis.

Andrade, Roberto A; Evans, Richard T; Hamill, Richard J; Zerai, Teddy; Giordano, Thomas P

Andrade, Roberto A; Evans, Richard T; Hamill, Richard J; Zerai, Teddy; Giordano, Thomas P.

Affiliation

Andrade RA; Section of Infectious Diseases, Baylor College of Medicine, Houston, TX 77009, USA. randrade@bcm.tmc.edu

Ann Pharmacother ; 43(5): 908-13, 2009 May.

Article in En | MEDLINE | ID: mdl-19401476

Subject(s)

Anti-HIV Agents/administration & dosage; HIV Infections/complications; HIV Infections/drug therapy; Histoplasmosis/complications; Histoplasmosis/drug therapy; Itraconazole/administration & dosage; Protease Inhibitors/administration & dosage; Adult; Antiretroviral Therapy, Highly Active; Drug Interactions; Female; HIV Reverse Transcriptase/antagonists & inhibitors; Humans; Itraconazole/blood; Male; Middle Aged; Retrospective Studies; Time Factors

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Protease Inhibitors / HIV Infections / Itraconazole / Anti-HIV Agents / Histoplasmosis Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Year: 2009 Type: Article

Fulltext

XML

PubMed Links

Search on Google